PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.31%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.07%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-9.04%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-1.78%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
-0.79%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.47%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.44%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.16%
Dividend reduction while NXPI stands at 0.69%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-48.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-53.02%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
133.94%
Similar 10Y revenue/share CAGR to NXPI's 123.54%. Walter Schloss might see both firms benefiting from the same long-term demand.
38.70%
5Y revenue/share CAGR at 75-90% of NXPI's 43.53%. Bill Ackman would encourage strategies to match competitor’s pace.
28.08%
3Y revenue/share CAGR above 1.5x NXPI's 12.05%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
498.85%
10Y OCF/share CAGR above 1.5x NXPI's 160.28%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
175.85%
Positive OCF/share growth while NXPI is negative. John Neff might see a comparative advantage in operational cash viability.
116.94%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
9620.45%
Net income/share CAGR above 1.5x NXPI's 97.28% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
187.69%
Positive 5Y CAGR while NXPI is negative. John Neff might view this as a strong mid-term relative advantage.
83.48%
3Y net income/share CAGR 75-90% of NXPI's 93.72%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
25.60%
Equity/share CAGR of 25.60% while NXPI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-7.65%
Negative 5Y equity/share growth while NXPI is at 712.41%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-6.64%
Negative 3Y equity/share growth while NXPI is at 3.58%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
597.21%
Dividend/share CAGR of 597.21% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
156.46%
Dividend/share CAGR of 156.46% while NXPI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.64%
3Y dividend/share CAGR of 102.64% while NXPI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
19.30%
AR growth well above NXPI's 1.01%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.88%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.79%
Positive asset growth while NXPI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.87%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
21.41%
We have some new debt while NXPI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-2.75%
Our R&D shrinks while NXPI invests at 2.98%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
No Data
No Data available this quarter, please select a different quarter.